We understand these are trying times and we are here to help keep your research moving forward.

As we closely monitor the situation at hand, rPeptide will remain fully operational and continue to practice all safety protocol while taking precautionary measures to ensure there are no interruptions to your research. From our catalog products to our laboratory services, please let us know how we can assist with your research needs.


ORDER ONLINE  •  CALL 866.753.0747  •  FAX 678.753.0746

Beta Amyloid Citations: 2020

Meyer, S., Schaeverbeke,J., Verbek, I., Gille, B., Schaepdryver, M., Luckett, E., Gabel, S., Bruffaerts, R., Mauroo, K., Thijssen, E., Stoops, E., Vanderstichele, H., Teunissen, C., Vandenberghe, R., Poesen, K. (2020) Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis. Alzheimer's Research & Therapy; https://doi.org/10.1186/s13195-020-00728-w.
Ding, Y., Zhong, Y., Baldshwiler, A., Abner, E., Bauer, B., Hartz, A. (2020) Protecting P-glycoprotein at the Blood-Brain Barrier from Degradation in an Alzheimer’s Disease Mouse Model. Research Square; DOI: https://doi.org/10.21203/rs.3.rs-116503/v1.
Hemion, C., Li,J.,Kohler,C., Scholl, H.P.N., Meyer, P., Killer, H., Neutzner,A. (2020) Clearance of neurotoxic peptides and proteins by meningothelial cells. Experimental Cell Research; https://doi.org/10.1016/j.yexcr.2020.112322.
Yang, T., Tran, K., Zeng, A., Massa, S., Longo, F. (2020) Small molecule modulation of the p75 neurotrophin receptor inhibits multiple amyloid beta-induced tau pathologies. Scientific Reports; https://doi.org/10.1038/s41598-020-77210-y.
Wnuk, A., et al (2020) Selective Targeting of Non-nuclear Estrogen Receptors with PaPE-1 as a New Treatment Strategy for Alzheimer’s Disease. Springer Open Choice; https://dx.doi.org/10.1007%2Fs12640-020-00289-8.
Ikenoue, T., Aprile, F.A., Sormanni, P. et al. (2020) A rationally designed bicyclic peptide remodels Aβ42 aggregation in vitro and reduces its toxicity in a worm model of Alzheimer’s disease. Sci Rep.; https://doi.org/10.1038/s41598-020-69626-3.
Kravenska,Y., Nieznanska,H., Nieznanski,K., Lukyanetz,E., Szewczyk,A., Koprowski,P., (2020) The monomers, oligomers, and fibrils of amyloid-β inhibit the activity of mitoBKCa channels by a membrane-mediated mechanism. BBA; https://doi.org/10.1016/j.bbamem.2020.183337.
Lv, J., Chen, L., et al (2020) Beta amyloid-induced time-dependent learning and memory impairment: involvement of HPA axis dysfunction. Metabolic Brain Disease; https://doi.org/10.1007/s11011-020-00613-3.
Boulo,S., Kuhlmann,J., Andreasson,U., Venkataraman,I., Herbst,V., Rutz,S., Manuilova,E., Vandijck,M., Dekeyser,F., Bjerke,M., Pannee,J., Charoud-Got,J., Auclair,G., Mazoua,S., Pinski,G., Trapmann,S., Schimmel,H., Emons, H., Quaglia,M., Portelius,E., Korecka, M., Shaw,L., Lame,M., Chambers, E., Vanderstichele,H., Stoops, E., Leinenbach, A., Bittner,T., Jenkins,R., Kostanjevecki,V., Lewczuk,P., Gobom,J., Zetterberg,H., Zegers,I., Blennow,K. (2020) First amyloid β1‐42 certified reference material for re‐calibrating commercial immunoassays. Alzheimer's Association; https://doi.org/10.1002/alz.12145.
Lackie,R., Marques-Lopes,J., Ostapchenko,V., Good,S., Choy,W., Oosten-Hawle, P., Pasternak,S., Prado,V., Prado,M. (2020) Increased levels of Stress-inducible phosphoprotein-1 accelerates amyloid-β deposition in a mouse model of Alzheimer’s disease. Acta Neuropathologica Communications; https://doi.org/10.1186/s40478-020-01013-5.
Qiu, Y., et al (2020) Predicting Thioflavin Fluorescence of Retinal Amyloid Deposits Associated With Alzheimer's Disease from Their Polarimetric Properties. Translational Vision Science & Technology; https://doi.org/10.1167/tvst.9.2.47.
Neddens,J., Daurer,M., Flunkert,S., Beutl,K., Loeffler,T., Walker,L., Attems,J., Hutter-Paier,B., (2020) Correlation of pyroglutamate amyloid β and ptau Ser202/Thr205 levels in Alzheimer’s disease and related murine models. PLOS ONE; https://doi.org/10.1371/journal.pone.0235543.
Vermeire, P., Schepdael, A., Petersen, N. (2020) Development of a novel sheathless CE-ESI-MS interface via a CO2 laser ablated opening. Talanta; https://doi.org/10.1016/j.talanta.2020.120853.
Fujita,Y., Maeda,T., Sato,C., Sato,M., Hatakeyama,H., Ota,Y., Iwabuchi,N., Tatesawa,K., Nomura,A., Zou,K., Komano,H. (2020) Engulfment of Toxic Amyloid β-protein in Neurons and Astrocytes Mediated by MEGF10. Neuroscience; https://doi.org/10.1016/j.neuroscience.2020.07.016.
Sohrabi, M., et al (2020) IGF-1R Inhibitor Ameliorates Neuroinflammation in an Alzheimer’s Disease Transgenic Mouse Model. Frontiers; https://doi.org/10.3389/fncel.2020.00200.
Henjum,K., Arskog,V., Jendresen,C.,Fladby,T., Torp,R., Nilsson,L. (2020) Analyzing microglial-associated Aβ in Alzheimer’s disease transgenic mice with a novel mid-domain Aβ-antibody. Scientific Reports; https://doi.org/10.1073/pnas.1700239114.
X. Tan, H. Guan, Y. Yang, et al. (2020) Cu(II) disrupts autophagy-mediated lysosomal degradation of oligomeric Aβ in microglia via mTOR-TFEB pathway. Toxicology and Applied Pharmacology; https://doi.org/10.1016/j.taap.2020.115090.
Michiels, E., Roose, K., Gallardo, R. et al. (2020) Reverse engineering synthetic antiviral amyloids. Nature Communications; https://doi.org/10.1038/s41467-020-16721-8.
Caneus,J., Akanda, N., Rumsey,J.,Guo, X., Jackson, M., Long, C., Sommerhage, F., Georgieva, S., Kanaan, N., Morgan, D., Hickman, J. (2020) A human induced pluripotent stem cell‐derived cortical neuron human‐on‐a chip system to study Aβ42 and tau‐induced pathophysiological effects on long‐term potentiation. Alzheimer's & Dementia; doi: 10.1002/trc2.12029.
Natarajan, K., Ullgren, A., Khoshnood, B., Johansson, C., Laffita-Mesa, J., Pannee, J., Zetterberg, H., Blennow, K., Graff, C. (2020) Plasma metabolomics of presymptomatic PSEN1-H163Y mutation carriers: A pilot study. bioRxiv; doi: https://doi.org/10.1101/2020.05.16.093559..
Wallin, C., Jarvet, J., Biverstal, H., Warmlander, S., Danielsson, J., Graslund, A., Abelein, A. (2020) Metal ion coordination delays amyloid-β peptide self-assembly by forming an aggregation-inert complex. Journal of Biological Chemistry; doi: 10.1074/jbc.RA120.012738.
Al-Edresi, A., Alsalahat, I., Freeman, S., Aojula, H., Penny,J. (2020) Resveratrol-mediated cleavage of amyloid β1-42 peptide; potential relevance to Alzheimer’s disease. Neurobiology of Aging; https://doi.org/10.1016/j.neurobiolaging.2020.04.012.
Maina, M., Mengham, K., Burra, G., Al-Hilaly,Y., Serpell, L. (2020) Dityrosine cross-link trapping of amyloid-β intermediates reveals that self-assembly is required for Aβ-induced cytotoxicity. bioRxiv; https://www.biorxiv.org/content/10.1101/2020.03.25.007690v1.full.
Alghazwi, M., Charoensiddhi, S., Smide, S., Zhang, W. (2020) Impact of Ecklonia radiata extracts on the neuroprotective activities against amyloid beta (Aβ1-42) toxicity and aggregation. Journal of Functional Food; https://doi.org/10.1016/j.jff.2020.103893.
Wilhelmus, M., Jongenelen, C., Bol, J., Druckarch, B (2020) Interaction between tissue transglutaminase and amyloid-beta: Protein-protein binding versus enzymatic crosslinking. Analytical Biochemistry; https://doi.org/10.1016/j.ab.2020.113578.
Kravenska, Y.,Nieznanska, H., Nieznanski, K., Lukyanetz, E., Szewczyk, A., Koprowski, P. (2020) The monomers, oligomers, and fibrils of amyloid-β inhibit the activity of mitoBKCa channels by a membrane-mediated mechanism. Biochimica et Biophysica Acta (BBA); Biomembranes; doi.org/10.1016/j.bbamem.2020.183337..
Wei, Z., Meng, X., Fatimy, R., Sun, B., Mai, D., Zhang, J., Arora, R., Zeng, A., Xu, P., Qu, S., Krichevsky, A., Selkoe, D., Li, S., (2020) Environmental enrichment prevents Aβ oligomer-induced synaptic dysfunction through mirna-132 and hdac3 signaling pathways (2020).. Neurobiology of Disease; https://doi.org/10.1016/j.nbd.2019.104617.
Dekens, D., Deyn, P., Sap, F., Eisel, U., Naude, P., (2020) Iron chelators inhibit amyloid-β-induced production of lipocalin 2 in cultured astrocytes (2020).. Neurochemistry International; https://doi.org/10.1016/j.neuint.2019.104607.